Company Description

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea.

Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.

The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Nyxoah SA

Country	Belgium
Founded	2009
IPO Date	Jul 2, 2021
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	154
CEO	Olivier Taelman

Contact Details

Address: Rue Edouard Belin 12 Mont-Saint-Guibert, 1435 Belgium
Phone	32 1 045 90 75
Website	nyxoah.com

Name	Position
Olivier Taelman	Chief Executive Officer and Executive Director
Robert Taub MBA	Co-Founder and Chairman
Bruno Onkelinx	Chief Technical Officer
John Landry	Chief Financial Officer
Jeyakumar Subbaroyan	Chief Science Officer
Pearson Dennis	Investor Relations Associate
An Moonen	General Counsel
Geeta Kaveti	Chief Compliance Officer
Maggie McGowan	Chief Human Resources Officer
Loic Moreau	President of International